John Katzenellenbogen

John Katzenellenbogen

University of Illinois at Urbana-Champaign

H-index: 116

North America-United States

About John Katzenellenbogen

John Katzenellenbogen, With an exceptional h-index of 116 and a recent h-index of 48 (since 2020), a distinguished researcher at University of Illinois at Urbana-Champaign, specializes in the field of Chemistry, pharmacology, PET imaging, breast cancer.

His recent articles reflect a diverse array of research interests and contributions to the field:

Asymmetric Allostery in Estrogen Receptor-α Homodimers Drives Responses to the Ensemble of Estrogens in the Hormonal Milieu

Reprogramming of endothelial gene expression by tamoxifen inhibits angiogenesis and ERα-negative tumor growth

Abstract PO3-29-03: An Emerging Class of ER mutations Enhances ER Dimerization and Promotes ER Activity

Abstract B010: Development of folate receptor alpha targeted FOXM1 inhibitors for ovarian cancer

ESR1 F404 Mutations and Acquired Resistance to Fulvestrant in ESR1-Mutant Breast Cancer

Somatic estrogen receptor α mutations that induce dimerization promote receptor activity and breast cancer proliferation

Endothelial ERα promotes glucose tolerance by enhancing endothelial insulin transport to skeletal muscle

Effective combination treatments for breast cancer inhibition by FOXM1 inhibitors with other targeted cancer drugs

John Katzenellenbogen Information

University

Position

___

Citations(all)

53705

Citations(since 2020)

10029

Cited By

47017

hIndex(all)

116

hIndex(since 2020)

48

i10Index(all)

568

i10Index(since 2020)

216

Email

University Profile Page

University of Illinois at Urbana-Champaign

Google Scholar

View Google Scholar Profile

John Katzenellenbogen Skills & Research Interests

Chemistry

pharmacology

PET imaging

breast cancer

Top articles of John Katzenellenbogen

Title

Journal

Author(s)

Publication Date

Asymmetric Allostery in Estrogen Receptor-α Homodimers Drives Responses to the Ensemble of Estrogens in the Hormonal Milieu

bioRxiv

Charles K Min

Jerome C Nwachukwu

Yingwei Hou

Robin Russo

Alexandra Papa

...

2024

Reprogramming of endothelial gene expression by tamoxifen inhibits angiogenesis and ERα-negative tumor growth

Theranostics

Chanaëlle Fébrissy

Marine Adlanmerini

Christel Péqueux

Frédéric Boudou

Mélissa Buscato

...

2024

Abstract PO3-29-03: An Emerging Class of ER mutations Enhances ER Dimerization and Promotes ER Activity

Cancer Research

Seema Irani

Wuwei Tan

Qing Li

Weiyi Toy

Catherine Jones

...

2024/5/2

Abstract B010: Development of folate receptor alpha targeted FOXM1 inhibitors for ovarian cancer

Cancer Research

Adam R Karpf

Makenzie Vorderbruggen

Pedram Rikhtechi

Catalina Muñoz-Trujillo

Cassie Liu

...

2024/3/4

ESR1 F404 Mutations and Acquired Resistance to Fulvestrant in ESR1-Mutant Breast Cancer

Cancer Discovery

Belinda Kingston

Alex Pearson

Maria Teresa Herrera-Abreu

Li-Xuan Sim

Rosalind J Cutts

...

2024/2/8

Somatic estrogen receptor α mutations that induce dimerization promote receptor activity and breast cancer proliferation

The Journal of Clinical Investigation

Seema Irani

Wuwei Tan

Qing Li

Weiyi Toy

Catherine Jones

...

2024/1/2

Endothelial ERα promotes glucose tolerance by enhancing endothelial insulin transport to skeletal muscle

Nature communications

Anastasia Sacharidou

Ken Chambliss

Jun Peng

Jose Barrera

Keiji Tanigaki

...

2023/8/17

Effective combination treatments for breast cancer inhibition by FOXM1 inhibitors with other targeted cancer drugs

Breast Cancer Research and Treatment

Valeria Sanabria Guillen

Yvonne Ziegler

Chirag Gopinath

Sandeep Kumar

Parama Dey

...

2023/4

Targeting the oncogenic transcription factor FOXM1 to improve outcomes in all subtypes of breast cancer

Benita S Katzenellenbogen

Valeria Sanabria Guillen

John A Katzenellenbogen

2023/6/27

Stringing along the estrogen receptor to engage with DNA

Proceedings of the National Academy of Sciences

John A Katzenellenbogen

2023/3/14

Antiestrogen compounds

2023/6/6

Inhibiting FOXM1 Sensitizes Myeloma Cells to BCL2 Inhibitor Venetoclax By Repressing MYC Pathway

Blood

Vivian Zhou

Luke Moat

Manya Yu

Deepak Parashar

Abdul Shour

...

2023/11/28

[18F]Tosyl fluoride as a versatile [18F]fluoride source for the preparation of 18F-labeled radiopharmaceuticals

Scientific reports

Dong Zhou

Wenhua Chu

Jinbin Xu

Sally Schwarz

John A Katzenellenbogen

2023/2/23

NB compound FOXM1 inhibitors have potent anti-cancer activity in high-grade serous ovarian carcinoma

Cancer Research

Makenzie Vorderbruggen

Cassie Liu

Catalina Muñoz Trujillo

Sung Hoon Kim

John A Katzenellenbogen

...

2023/4/4

Estrogen receptor beta ligands for the prevention and treatment of multiple sclerosis (ms) and other demyelinating, inflammatory and neurodegenerative diseases

2023/11/9

Full wwPDB X-ray Structure Validation Report i

Y Kim

KH Kim

2023

FOXM1 inhibition: A novel therapeutic approach for small cell lung cancer

Cancer Research

Md Arafat Khan

Parvez Khan

Mahek Fatima

Asad Ur Rehman

Shailendra Kumar Maurya

...

2023/4/4

OR11-01 A New Model for Estrogen Receptor-alpha Antagonist Mechanism of Action

Journal of the Endocrine Society

Jerome C Nwachukwu

Jacqline W Njeri

Thomas Venables

Ciaran Seath

Matthew E Pipkin

...

2023/10

Coordinated activation of c-Src and FOXM1 drives tumor cell proliferation and breast cancer progression

The Journal of Clinical Investigation

Ipshita Nandi

Harvey W Smith

Virginie Sanguin-Gendreau

Linjia Ji

Alain Pacis

...

2023/4/3

New 1, 1-diarylethylene FOXM1 inhibitors potently reduce intracellular FOXM1 and suppress high-grade serous ovarian carcinoma cell viability

Cassie Liu

Catalina Muñoz-Trujillo

Sung Hoon Kim

John A Katzenellenbogen

Benita S Katzenellenbogen

...

2022/1/25

See List of Professors in John Katzenellenbogen University(University of Illinois at Urbana-Champaign)